Skip to main content
Veterinary Medicines

Butador 10 mg/ml Solution for Injection for Horses, Dogs and Cats

Authorised
  • Butorphanol tartrate

Product identification

Medicine name:
Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen
Butador 10 mg/ml Solution for Injection for Horses, Dogs and Cats
Active substance:
  • Butorphanol tartrate
Target species:
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol tartrate
    14.58
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
  • Intravenous use
    • Dog
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Available in:
  • United Kingdom (Northern Ireland)
Package description:
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 50 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 10 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Richter Pharma AG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 22080/4002
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0005/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."